Bristol Expands R&D In India Through Biocon Deal
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb is expanding its research and development presence in India through a deal with Bangalore-based Biocon on discovery research work involving medicinal chemistry, biology and drug metabolism, the firms announced March 14